✦ LIBER ✦

P-207 Docetaxel and irinotecan as first line chemotherapy in patients with unresectable locally advanced or metastatic non small cell lung cancer (NSCLC): A phase II study

✍ Scribed by Groth, Gesine; Reck, Martin; Wilke, Hansjochen; Büchele, Thomas; Schäfer, Klaus; Gatzemeier, Ulrich

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of docetaxel and cisplati

✍ Y. H. Kim; J. S. Kim; Y. H. Choi; K. H. In; H. S. Park; D. S. Hong; T. J. Jeong; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 67 KB

Docetaxel–carboplatin chemotherapy combi

✍ Fischer, J.R.; Griesinger, F.; Fink, T.; Salm, T.; Marseille, A.; Wolf, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Weekly chemotherapy with carboplatin, do

✍ D Pectasides; A Visvikis; A Kouloubinis; J Glotsos; N Bountouroglou; N Karvounis 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

P-449 Docetaxel in combination carboplat

✍ Barata, F.; Camacho, E.; Sousa, A.; Costa, M.S.; Resende, R.; Meleiro, A.; Nogue 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase II study of Docetaxel and Cisplati

✍ Pawel, J.v.; Faderl, B.; Wagner, H.; Krauβ, C.; Achterrath, W. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 90 KB